Results 61 to 70 of about 31,798 (272)

Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival

open access: yesEuropean Journal of Haematology, EarlyView.
ABSTRACT Background Polycythemia vera (PV) and essential thrombocythemia (ET) are associated with a well‐recognized increased risk of thrombotic events, bleeding, and all‐cause mortality, but the frequency of these outcomes during treatment has rarely been assessed in large cohorts.
Anneli Enblom Larsson   +5 more
wiley   +1 more source

Nine treatments of 1000 mL therapeutic phlebotomy in a subject with polycythemia: A case report

open access: yesPhysiological Reports
Large‐volume therapeutic phlebotomy is the mainstay of hemochromatosis treatment and offers an opportunity to investigate the hemodynamic changes during acute hypovolemia. An otherwise healthy 64‐year‐old male with hemochromatosis participated.
William J. Morton   +5 more
doaj   +1 more source

Blood Harmane Concentrations in 497 Individuals Relative to Coffee, Cigarettes, and Food Consumption on the Morning of Testing

open access: yesJournal of Toxicology, 2011
Harmane, a potent neurotoxin linked with several neurological disorders, is present in many foods, coffee, and cigarettes. We assessed whether morning food/coffee consumption and smoking were reflected in blood harmane concentrations (BHCs) we obtained ...
Elan D. Louis   +4 more
doaj   +1 more source

Hybrid Management of an Ulnar Artery Pseudoaneurysm Postphlebotomy

open access: yesJournal of Clinical Interventional Radiology ISVIR, 2019
The purpose of this case report is to describe the occurrence and management of an ulnar artery pseudoaneurysm post phlebotomy. A 36-year-old worker with progressively painful nondominant forearm swelling was referred at 4 weeks postphlebotomy.
Heather K. Moriarty   +5 more
doaj   +1 more source

Phlebotomy Puncture Juncture [PDF]

open access: yesLaboratory Medicine, 2005
The number of patients that may be harmed while undergoing phlebotomy 1 procedures is enormous based on a consideration of sheer numbers alone. In this country, we estimate more than 1 billion venipunctures are performed annually. The Fall 2004 BOR Newsletter lists the fact that 26,773 phlebotomy technicians have been certified since the PBT registry ...
Helen Ogden-Grable, Gary W. Gill
openaire   +1 more source

Indications and use of therapeutic phlebotomy in polycythemia vera: which role for erythrocytapheresis?

open access: yesLeukemia, 2018
The Italian Societies of Hematology and Blood Transfusion issued recent recommendations for phlebotomy in polycythemia vera (PV), to obtain a target hematocrit
L. Teofili   +3 more
semanticscholar   +1 more source

Retrieval of fractured dialysis catheter through phlebotomy of internal jugular vein: a case report [PDF]

open access: gold, 2021
Huizhen Wu   +4 more
openalex   +1 more source

Effects of Oral Single‐Dose Empagliflozin on Urinary Glucose, Serum β‐Hydroxybutyrate, and Plasma Empagliflozin Concentrations in Healthy Adult Dogs

open access: yesJournal of Veterinary Pharmacology and Therapeutics, EarlyView.
ABSTRACT Empagliflozin is a sodium‐glucose cotransporter‐2 inhibitor used for treating humans with heart failure, among other conditions. This drug could have applications in veterinary cardiology, but whether empagliflozin has biological effects in dogs when administered at dosages approximating human therapeutic dosages is unknown.
Andrea D. Plá Gutierrez   +5 more
wiley   +1 more source

Perinatal clinical management of a rare ABh variant blood group

open access: yesTransfusion Medicine, EarlyView.
Abstract Background The H antigen, precursor of the A and B blood groups, is a high‐prevalence antigen. Very few H antigen‐negative (H−) blood donors are available in the United Kingdom. Case Presentation We present the case of a second pregnancy in a 28‐year‐old woman with the very rare ABh phenotype, and the presence of anti‐H, anti‐A and anti‐B ...
Aritri Mandal   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy